Reports for UPJOHN CANADA ULC

Company Name

UPJOHN CANADA ULC

Totals

Shortage reports

53

Actual shortage: 1 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 2 (4%)
Resolved: 50 (94%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (2%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
REVATIO 0.8MG SOLUTION Resolved 2018-10-10 2018-12-18 63649
REVATIO 0.8MG SOLUTION Resolved 2020-04-03 2020-08-07 110817
REVATIO 0.8MG SOLUTION Resolved 2020-11-11 2021-01-21 128257
ZOLOFT 100MG CAPSULE Resolved 2020-04-02 2020-05-07 110538
ZOLOFT 100MG CAPSULE Resolved 2022-06-01 2022-07-21 161625
NEURONTIN 100MG CAPSULE Avoided shortage 2017-12-20 2018-02-07 33933
CELEBREX 100MG CAPSULE Resolved 2017-04-20 2017-06-28 7489
GD-AMLODIPINE/ATORVASTATIN 10MG 80MG TABLET Resolved 2020-01-22 2020-04-22 103957
NORVASC 10MG TABLET Resolved 2019-03-04 2020-01-18 77476
DILANTIN-125 SUSPENSION 125MG SUSPENSION Resolved 2021-12-13 2022-04-01 151037
XANAX 1MG TABLET Resolved 2018-08-04 2018-09-05 57537
XANAX 1MG TABLET Resolved 2019-06-27 2019-08-08 87576
XANAX 1MG TABLET Actual shortage 2022-06-15 2022-08-01 162663
DETROL 1MG TABLET Resolved 2017-09-21 2017-11-02 22963
DETROL 1MG TABLET Resolved 2018-02-02 2018-03-07 38160
DETROL 1MG TABLET Resolved 2019-10-10 2020-01-08 96055
ZELDOX 20.0MG CAPSULE Resolved 2019-09-24 2019-11-19 94573
CELEBREX 200MG CAPSULE Resolved 2022-04-05 2022-06-04 157914
REVATIO 20MG TABLET Resolved 2017-03-13 2017-03-18 2036
GD-ELETRIPTAN 20MG TABLET Resolved 2020-12-16 2021-01-12 130219

Showing 1 to 20 of 53

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0